JCR Financial Statements From 2010 to 2025
| JCRRFDelisted Stock | USD 5.00 0.00 0.00% |
Check JCR Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among JCR Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . JCR financial statements analysis is a perfect complement when working with JCR Pharmaceuticals Valuation or Volatility modules.
JCR |
JCR Pharmaceuticals Co Company Return On Asset Analysis
JCR Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current JCR Pharmaceuticals Return On Asset | 0.0441 |
Most of JCR Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, JCR Pharmaceuticals Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, JCR Pharmaceuticals Co has a Return On Asset of 0.0441. This is 100.5% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The return on asset for all United States stocks is 131.5% lower than that of the firm.
JCR Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining JCR Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare JCR Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across JCR Pharmaceuticals competition to find correlations between indicators driving JCR Pharmaceuticals's intrinsic value. More Info.JCR Pharmaceuticals Co is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.43 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for JCR Pharmaceuticals Co is roughly 2.31 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the JCR Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About JCR Pharmaceuticals Financial Statements
JCR Pharmaceuticals stakeholders use historical fundamental indicators, such as JCR Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although JCR Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in JCR Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on JCR Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in JCR Pharmaceuticals Co. Please read more on our technical analysis and fundamental analysis pages.
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan. Jcr Pharmaceuticals is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in JCR Pink Sheet
If you are still planning to invest in JCR Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the JCR Pharmaceuticals' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |